{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:40:10Z","timestamp":1786552810466,"version":"build-2736575974"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03004","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:08:47Z","timestamp":1545350927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Antibody Repertoire Analysis of Hepatitis C Virus Infections Identifies Immune Signatures Associated With Spontaneous Clearance"],"prefix":"10.3389","volume":"9","author":[{"given":"Sivan","family":"Eliyahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oz","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiri","family":"Elmedvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reut","family":"Timor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ateret","family":"Davidovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Vigneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Clouser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assy","family":"Nimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaacov Y.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pazit","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gur","family":"Yaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meital","family":"Gal-Tanamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/17512433.2017.1313111","article-title":"Why highly effective drugs are not enough: the need for an affordable solution to eliminating HCV","volume":"10","author":"Hayes","year":"2017","journal-title":"Exp Rev Clin Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1412840","DOI":"10.1155\/2016\/1412840","article-title":"State of the art, unresolved issues, and future research directions in the fight against hepatitis C virus: perspectives for screening, diagnostics of resistances, and immunization","volume":"2016","author":"Trucchi","year":"2016","journal-title":"J Immunol Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/liv.12063","article-title":"Best strategies for global HCV eradication","volume":"33","author":"Hagan","year":"2013","journal-title":"Liver Int Offic J Int Assoc Study Liver"},{"key":"B5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.coi.2015.06.010","article-title":"Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?","volume":"35","author":"Walker","year":"2015","journal-title":"Curr Opin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1055\/s-0034-1371081","article-title":"Will there be a vaccine to prevent HCV infection?","volume":"34","author":"Honegger","year":"2014","journal-title":"Semin Liver Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fimmu.2014.00550","article-title":"The humoral immune response to HCV: understanding is key to vaccine development","volume":"5","author":"Cashman","year":"2014","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1189\/jlb.4RI0214-126R","article-title":"Immune control and failure in HCV infection\u2013tipping the balance","volume":"96","author":"Dustin","year":"2014","journal-title":"J Leukocyte Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.antiviral.2014.06.018","article-title":"Hepatitis C: the next 25years","volume":"110","author":"Houghton","year":"2014","journal-title":"Antiviral Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.coviro.2017.03.014","article-title":"Designing an HCV vaccine: a unique convergence of prevention and therapy?","volume":"23","author":"Walker","year":"2017","journal-title":"Curr Opin Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"E6946","DOI":"10.1073\/pnas.1614942113","article-title":"Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: implications for vaccine design","volume":"113","author":"Pierce","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/hep.23862","article-title":"Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus","volume":"52","author":"Ndongo","year":"2010","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"10280","DOI":"10.1128\/JVI.00874-14","article-title":"Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain","volume":"88","author":"Sabahi","year":"2014","journal-title":"J Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1128\/JVI.02190-14","article-title":"Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies","volume":"89","author":"Meola","year":"2015","journal-title":"J Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1021\/acsinfecdis.6b00110","article-title":"Structure and function of the hepatitis C virus envelope glycoproteins E1 and E2: antiviral and vaccine targets","volume":"2","author":"Freedman","year":"2016","journal-title":"ACS Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.coviro.2015.04.001","article-title":"Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design","volume":"11","author":"Kong","year":"2015","journal-title":"Curr Opin Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antiviral Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1002895","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathog."},{"key":"B24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1126\/scitranslmed.3009512","article-title":"Broadly neutralizing antibodies abrogate established hepatitis C virus infection","volume":"6","author":"de Jong","year":"2014","journal-title":"Sci Transl Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0165047","DOI":"10.1371\/journal.pone.0165047","article-title":"Hepatitis C virus broadly neutralizing monoclonal antibodies isolated 25 years after spontaneous clearance","volume":"11","author":"Merat","year":"2016","journal-title":"PloS ONE"},{"key":"B26","doi-asserted-by":"publisher","first-page":"92872","DOI":"10.1172\/jci.insight.92872","article-title":"Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance","volume":"2","author":"Bailey","year":"2017","journal-title":"JCI Insight"},{"key":"B27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nbt.2782","article-title":"The promise and challenge of high-throughput sequencing of the antibody repertoire","volume":"32","author":"Georgiou","year":"2014","journal-title":"Nat Biotech."},{"key":"B28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2567.2011.03527.x","article-title":"Rep-Seq: uncovering the immunological repertoire through next-generation sequencing","volume":"135","author":"Benichou","year":"2012","journal-title":"Immunology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1126\/science.1225416","article-title":"Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses","volume":"337","author":"Burton","year":"2012","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nbt.1673","article-title":"Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells","volume":"28","author":"Reddy","year":"2000","journal-title":"Nat Biotech."},{"key":"B31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1474-9726.2008.00443.x","article-title":"B-cell diversity decreases in old age and is correlated with poor health status","volume":"8","author":"Gibson","year":"2009","journal-title":"Aging Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/gene.2012.12","article-title":"The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease","volume":"13","author":"Watson","year":"2012","journal-title":"Gene Immun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.chom.2013.05.008","article-title":"Convergent antibody signatures in human dengue","volume":"13","author":"Parameswaran","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature13764","article-title":"Rapid development of broadly influenza neutralizing antibodies through redundant mutations","volume":"516","author":"Pappas","year":"2014","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1003754","DOI":"10.1371\/journal.ppat.1003754","article-title":"The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies","volume":"9","author":"Sok","year":"2013","journal-title":"PLoS pathog."},{"key":"B36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nm.2656","article-title":"High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions","volume":"18","author":"Di Niro","year":"2012","journal-title":"Nat Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1038\/ncomms5167","article-title":"Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients","volume":"5","author":"Cho","year":"2014","journal-title":"Nat Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/JVI.01890-06","article-title":"Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus","volume":"81","author":"Yi","year":"2007","journal-title":"J Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1038\/nprot.2013.117","article-title":"Isolation of human monoclonal antibodies from peripheral blood B cells","volume":"8","author":"Huang","year":"2013","journal-title":"Nat Prot."},{"key":"B41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"Gottwein","year":"2009","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/nar\/27.1.209","article-title":"IMGT, the international ImMunoGeneTics database","volume":"27","author":"Lefranc","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-59745-554-1_3","article-title":"Design of a human synthetic combinatorial library of single-chain antibodies","volume":"525","author":"Nahary","year":"2009","journal-title":"Methods Molecul Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jim.2007.01.008","article-title":"Antibody internalization studied using a novel IgG binding toxin fusion","volume":"321","author":"Mazor","year":"2007","journal-title":"J Immunol Methods"},{"key":"B45","doi-asserted-by":"publisher","first-page":"19450","DOI":"10.1073\/pnas.0809879105","article-title":"In vitro selection of a neutralization-resistant hepatitis C virus escape mutant","volume":"105","author":"Gal-Tanamy","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B46","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1046\/j.1440-1711.2003.01171.x","article-title":"Why do B cells produce CD40 ligand?","volume":"81","author":"Wykes","year":"2003","journal-title":"Immunol Cell Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2013-06-506865","article-title":"IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts","volume":"122","author":"Berglund","year":"2013","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/scitranslmed.3008879","article-title":"B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes","volume":"6","author":"Stern","year":"2014","journal-title":"Sci Transl Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1073\/pnas.1118018109","article-title":"Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes","volume":"109","author":"Shiroguchi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B50","doi-asserted-by":"publisher","first-page":"171ra119","DOI":"10.1126\/scitranslmed.3004794","article-title":"Lineage structure of the human antibody repertoire in response to influenza vaccination","volume":"5","author":"Jiang","year":"2013","journal-title":"Sci Transl Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12865-014-0029-0","article-title":"Capturing needles in haystacks: a comparison of B-cell receptor sequencing methods","volume":"15","author":"Bashford-Rogers","year":"2014","journal-title":"BMC Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/bioinformatics\/btu138","article-title":"pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires","volume":"30","author":"Vander Heiden","year":"2014","journal-title":"Bioinformatics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/978-1-61779-842-9_3","article-title":"IMGT((R))","volume":"882","author":"Alamyar","year":"2012","journal-title":"Methods Molecul Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4161\/mabs.2.2.11301","article-title":"Accessing the human repertoire for broadly neutralizing HIV antibodies","volume":"2","author":"Hammond","year":"2000","journal-title":"mAbs"},{"key":"B55","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/prca.201600002","article-title":"Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display","volume":"10","author":"Kuhn","year":"2016","journal-title":"Proteom Clin Appl."},{"key":"B56","doi-asserted-by":"publisher","first-page":"10407","DOI":"10.1128\/JVI.74.22.10407-10416.2000","article-title":"Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes","volume":"74","author":"Hadlock","year":"2000","journal-title":"J Virol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"9224","DOI":"10.1128\/JVI.78.17.9224-9232.2004","article-title":"Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions","volume":"78","author":"Keck","year":"2004","journal-title":"J Virol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1099\/vir.0.83386-0","article-title":"Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein","volume":"89","author":"Owsianka","year":"2008","journal-title":"J General Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1002653","DOI":"10.1371\/journal.ppat.1002653","volume":"20128","author":"Keck","year":"","journal-title":"PLoS Pathog."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/nm.3963","article-title":"Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies","volume":"21","author":"Bhiman","year":"2015","journal-title":"Nat Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cell.2016.02.022","article-title":"Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody","volume":"165","author":"Bonsignori","year":"2016","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1128\/JVI.00198-11","article-title":"The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection","volume":"85","author":"Gray","year":"2011","journal-title":"J Virol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"20066","DOI":"10.1073\/pnas.1107498108","article-title":"Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation","volume":"108","author":"Glanville","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1182\/blood.V97.4.1023","article-title":"V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen","volume":"97","author":"Chan","year":"2001","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/hep.26524","article-title":"Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies","volume":"58","author":"Pedersen","year":"2013","journal-title":"Hepatology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/lt.24344","article-title":"Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A)","volume":"22","author":"O'Shea","year":"2016","journal-title":"Liver Transplant."},{"key":"B67","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/hep.510280333","article-title":"Predictors of patient and graft survival following liver transplantation for hepatitis C","volume":"28","author":"Charlton","year":"1998","journal-title":"Hepatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:08:53Z","timestamp":1545350933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2018.03004"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734676854.793555071","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"article-number":"3004"}}